Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2001, p. 2181-2182, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2181-2182.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
LETTERS TO THE EDITOR
Update on Rifampin Resistance in the Legionellaceae
 |
LETTER |
A recent article described rpoB mutations in 18 rifampin-resistant variants of Legionella spp.
(4). One of these 18 strains, isolate 8749, an in
vitro-generated high-level rifampin-resistant (MIC
256 µg/ml)
variant of K26, a susceptible clinical Legionella bozemanii
isolate, was shown to harbor no codon exchange in the cluster I
rpoB 69-bp hot spot, the DNA region investigated.
Besides codon exchanges in cluster I (e.g., codon 507 to 533 in
Escherichia coli), several mutations in at least three
rpoB regions outside cluster I have been described to be
associated with resistance to rifampin (1). Mutations
either are located 768 bp (in Mycobacterium tuberculosis) to
1,128 bp (in Helicobacter pylori) upstream of cluster I at
the beginning of rpoB (5' region; codon V146F in E. coli, V149F in H. pylori, and V176F in M. tuberculosis) or can be found in two regions 123 bp (cluster II)
and 468 to 471 bp (cluster III) downstream of cluster I (Fig.
1). Mutations in cluster II are
frequently associated with rifampin resistance; cluster III (R687H in
E. coli and R701H in H. pylori) is suspected to
confer very low levels of resistance.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Rifampin resistance-determining regions in
rpoB. Isoleucine codon positions and substitutions in
rpoB cluster II and the newly described tyrosine (Y)
substitution in L. bozemanii and threonine (T) substitution
in H. pylori are indicated.
|
|
Both the parent L. bozemanii strain K26 and the resistant
variant 8749 were reinvestigated. PCR primers were designed for amplification of sections encompassing the 5' region of rpoB
(bp
124 to 591) (RplL-F [forward
5'-GAAGARGCNGGYGCNGARGTDGA-3'] and L4 [reverse
5'-CAACCATGANCCNCGYTANGG-3']) and clusters I, II, and III
(bp 1396 to 2174) (Rif U1 [forward
5'-CGICGIGTTCGITCVGTWGGHGA-3'] and Rif D3 [reverse
5'-ATCAGATGCAACAATTCTTTCC-3']). Base pair numbering is
based on the published sequence of Legionella pneumophila (4) and the unfinished Legionella Genome Project of the
Columbia Genome Center (contig LP.WG.044.06.111099). IUB code is used
for mixed base sites. The PCR products were sequenced on both strands. The 5' region of rpoB (2), especially codon 159 (GTT, valine), was not changed. The only mutation detected (ATT to TAT)
was located in cluster II, downstream of the cluster I hot spot. This
mutation induces an isoleucine-to-tyrosine amino acid substitution at
position 587 of the protein sequence. In the great majority of cluster II mutations described to be associated with rifampin resistance in
other species, the corresponding codon is changed. Amino acid exchanges
in different species observed in our laboratory or found in the
literature are summarized in Fig. 1. Also included is a cluster II
isoleucine-to-threonine exchange (ATC to ACC, I586T) newly observed in
two (802-1 and 802-2) of three H. pylori DNA samples
provided by Wang et al., formerly described as rifampin resistant but
harboring wild-type sequence in clusters I and II (6). In
the third H. pylori DNA sample (802-3) from that study, amino acid exchange V149F, corresponding to the V146F exchange in
E. coli (2) and the V176F exchange in M. tuberculosis, could be observed.
In conclusion, no cluster I mutation was found in strain 8749 that
could explain the high level rifamycin resistance (4). Here we show that the isolate harbors a mutation in cluster II (I587Y),
inducing an amino acid substitution that is known to be associated with
rifamycin resistance in other species. In all comparable cases,
complete sequence analysis of the respective rpoB regions
(Fig. 1) revealed mutations corresponding to the Rif-resistant
phenotype of H. pylori and Legionella spp. and
also M. tuberculosis in our laboratory. To our knowledge,
mutations outside the cluster I rpoB hot spot in
Legionellaceae have not been described so far. This is also
the first description of I-to-Y and I-to-T substitutions in
cluster II.
 |
ACKNOWLEDGMENTS |
We thank Ge Wang and Diane Taylor for providing the DNA samples of
the rifampin-resistant H. pylori variants.
 |
FOOTNOTES |
*
Freiburg University
Herman-Herder-Strasse 11
D-79104 Freiburg, Germany
*
Phone: 49 761 2036546
Fax: 49 761 2036562
E-mail: Markus-heep{at}web.de
 |
REFERENCES |
| 1.
|
Heep, M.,
S. Odenbreit,
D. Beck,
J. Decker,
E. Prohaska,
U. Rieger, and N. Lehn.
2000.
Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins.
Antimicrob. Agents Chemother.
44:1713-1715[Abstract/Free Full Text].
|
| 2.
|
Lisitsyn, N. A.,
E. D. Sverdlov,
E. P. Moiseyeva,
O. N. Danilevskaya, and V. G. Nikiforov.
1984.
Mutation to rifampicin resistance at the beginning of the RNA polymerase beta subunit gene in Escherichia coli.
Mol. Gen. Genet.
196:173-174[CrossRef][Medline].
|
| 3.
|
Morse, R.,
K. O'Hanlon,
M. Virji, and M. D. Collins.
1999.
Isolation of rifampin-resistant mutants of Listeria monocytogenes and their characterization by rpoB gene sequencing, temperature sensitivity for growth, and interaction with an epithelial cell line.
J. Clin. Microbiol.
37:2913-2919[Abstract/Free Full Text].
|
| 4.
|
Nielsen, K.,
P. Hindersson,
N. Høiby, and J. M. Bangsborg.
2000.
Sequencing of the rpoB gene in Legionella pneumophila and characterization of mutations associated with rifampin resistance in the Legionellaceae.
Antimicrob. Agents Chemother.
44:2679-2683[Abstract/Free Full Text].
|
| 5.
|
Reynolds, M. G.
2000.
Compensatory evolution in rifampin-resistant Escherichia coli.
Genetics
156:1471-1481[Abstract/Free Full Text].
|
| 6.
|
Wang, G.,
T. J. Wilson,
Q. Jiang, and D. E. Taylor.
2001.
Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori.
Antimicrob. Agents Chemother.
45:727-733[Abstract/Free Full Text].
|
| 7.
|
Wichelhaus, T. A.,
V. Schafer,
V. Brade, and B. Boddinghaus.
1999.
Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
43:2813-2816[Abstract/Free Full Text].
|
| 8.
|
Yuen, L. K.,
D. Leslie, and P. J. Coloe.
1999.
Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia.
J. Clin. Microbiol.
37:3844-3850[Abstract/Free Full Text].
|
| | | | |
Annerose Serr
Barbara F. Koenig
Markus Heep*
Institut für Medizinische Mikrobiologie und Hygiene
|
| | | | |
Kim Nielsen
Aarhus University Hospital Aarhus, Denmark
|
| | | | |
Jette Marie Bangsborg
Herlev Hospital Herlev, Denmark
|
Antimicrobial Agents and Chemotherapy, July 2001, p. 2181-2182, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2181-2182.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.